Free tool
FAERS Monitor: Uceris
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203634 or its brand name (Uceris, Budesonide). Reports on generic versions are filed under their own applications.
Reports
42,217
Serious
32,256
76% of reports
Hospitalization
15,629
Death reported
3,140
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5,106
- off label use4,635
- dyspnoea4,608
- asthma3,635
- fatigue2,697
- condition aggravated2,549
- diarrhoea2,528
- headache2,513
- cough2,269
- pneumonia2,266
- nausea2,187
- wheezing2,029
- pyrexia1,954
- pain1,916
- weight decreased1,780
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 138 |
| 2005 | 220 |
| 2006 | 195 |
| 2007 | 197 |
| 2008 | 282 |
| 2009 | 292 |
| 2010 | 320 |
| 2011 | 533 |
| 2012 | 737 |
| 2013 | 796 |
| 2014 | 1,066 |
| 2015 | 1,568 |
| 2016 | 1,791 |
| 2017 | 2,031 |
| 2018 | 2,456 |
| 2019 | 3,073 |
| 2020 | 3,612 |
| 2021 | 3,784 |
| 2022 | 4,065 |
| 2023 | 4,011 |
| 2024 | 4,166 |
| 2025 | 4,033 |
| 2026 | 2,851 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,942 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| wheezingSignal | 2,029 | 17.6 | 16.9 | 30,780 |
| asthmaSignal | 3,635 | 16.5 | 16.0 | 51,571 |
| condition aggravatedSignal | 2,549 | 4.2 | 4.0 | 6,259 |
| dyspnoeaSignal | 4,608 | 4.1 | 4.0 | 10,920 |
| coughSignal | 2,269 | 4.1 | 3.9 | 5,249 |
| pneumoniaSignal | 2,266 | 3.5 | 3.4 | 4,088 |
| weight decreasedSignal | 1,780 | 3.2 | 3.0 | 2,694 |
| pyrexiaSignal | 1,954 | 2.8 | 2.7 | 2,325 |
| off label useSignal | 4,635 | 2.6 | 2.6 | 4,924 |
| headacheSignal | 2,513 | 2.0 | 1.9 | 1,291 |
| diarrhoea | 2,528 | 2.0 | 1.9 | 1,211 |
| drug ineffective | 5,106 | 1.9 | 1.9 | 2,446 |
| fatigue | 2,697 | 1.7 | 1.7 | 856 |
| pain | 1,916 | 1.6 | 1.5 | 390 |
| nausea | 2,187 | 1.4 | 1.3 | 234 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.